Search results for: Precision Medicine
Filter search results
Medical Research: How Long Does it Take?
10 February 2015
…They also measure elapsed times for a wide variety of very different kinds of innovations with rather different pathways between initial inspiration and eventual delivery of benefits: medicines, public health…
OHE at HTAi Oslo: A New Drug Development Paradigm, a Framework for Developing Formularies in MICs, and the Effect of NICE Decisions Abroad
15 June 2015
…companies, which set out development pathways for different drug ‘archetypes’ and (ii) initial findings from the Innovative Medicines Initiative (IMI) ‘GetReal’ Project proposing innovative (more pragmatic) trial designs in pre-and…
OHE at HTAi Oslo: A New Drug Development Paradigm, and the Effect of NICE Decisions Abroad
19 June 2015
…out development pathways for different drug ‘archetypes’ and (ii) initial findings from the Innovative Medicines Initiative (IMI) ‘GetReal’ Project proposing innovative (more pragmatic) trial designs in pre-and post-launch drug development….
European Union Pharmaceutical Markets: A Case for Differential Pricing?
11 August 2015
This article looks at how theory could be put into practice suggesting ways to implement a differential pricing system for branded medicines in the EU that can enhance overall welfare….
OHE’s submission to Belgium’s Committee on Health and Equal Opportunities argues value-based pricing delivers a ‘triple-win’
18 December 2024
…of Representatives. The two draft bills focus on compulsory insurance for medical care and benefits, one in regards to fair and objective prices for medicines, and the other to enable…
How to Manage Data Governance in an Era of Real World Evidence (RWE): Working Towards a Set of International Standards
24 November 2015
…and using it to support decision-making by regulators and payers is changing. Regulatory flexibilities and increasing public pressure to facilitate earlier access to medicines (e.g. through adaptive pathways or early…
Cost-per-QALY in the US and Britain
28 December 2015
…is Henry J. Kaiser Professor of Health Policy and Management, Harvard University School of Public Health, Professor of Medicine at the Harvard Medical School, and Director of the Program on…
OHE Appoints Principal Health Economist: Dr Alastair Fischer
14 March 2016
…a healthcare innovation How evidence-based medicine should be adapted for evaluation of public health and social care interventions. Over the years, Alastair has had wide teaching experience and has taught…
OHE Response: The National PROMs Programme Consultation
15 April 2016
…(in press) Calvert, M., Thwaites, R., Kyte, D., Devlin, N. 2015 Putting patient-reported outcomes on the ‘Big Data Road Map’ , Journal of the Royal Society of Medicine, 108(8), pp….